EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Long-term health-related quality of life and lifestyle behavior of patients with acute myeloid leukemia

Fabio Efficace iD, Laura Cannella, Xavier Thomas, Meltem Kurt Yuksel, Silvia Maria Trisolini, Saveria Capria, Francesco Sparano, Thomas Baldi, Ernesta Audisio, Luca Maurillo, Roberto Massimo Lemoli, Annalisa Imovilli und 12 weitere

The Oncologist · 2026

DOI: 10.1093/oncolo/oyag027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Oncologist, 2026. Verfasst von Fabio Efficace und 23 weiteren Autor:innen. Beteiligte Einrichtung: Data Center and Health Outcomes Research Unit, Italian Group for Adult Hematologic Diseases (GIMEMA), Rome 00182, Italy. Hauptthemen laut MEDLINE: Quality of Life, Leukemia, Myeloid, Acute, Life Style, Cancer Survivors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: EORTC Quality of Life Group.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Despite improvements in survival outcomes for acute myeloid leukemia (AML), limited evidence is available on health-related quality of life (HRQoL) and health problems experienced by long-term survivors. Patients and methods This international, cross-sectional study evaluated HRQoL, comorbidities, and lifestyle behaviors among long-term AML survivors enrolled from 24 centers across 6 countries. Health-related quality of life was assessed using the SF-36 and the EORTC QLQ-C30 questionnaires, while comorbidities were measured with an adapted version of the validated self-administered comorbidity questionnaire. Lifestyle factors, including physical activity, diet, smoking, alcohol consumption, and body mass index, were also assessed.

Results

Overall, 225 AML survivors were enrolled, with a median time since diagnosis of 8.8 years (IQR 6.4-11.9) and a median age of 58.9 years (IQR 49.0-67.0). Compared with the general population, AML survivors exhibited clinically relevant impairments in SF-36 physical functioning (Δ = −8.09, P < .001) and role physical scales (Δ = -11.09, P < .001), as well as clinically relevant lower physical component summary scores (Δ = -3.94, P < .001). Survivors treated with alloSCT reported worse HRQoL profiles compared with those treated with autoSCT or chemotherapy only. Comorbidities were highly prevalent (88.5%), with impaired vision, back pain, and arthrosis/arthritis being the most frequent. Analysis of lifestyle behaviors showed that 66.2% of AML survivors were physically inactive, 80.2% did not meet dietary recommendations, and 55.3% were overweight/obese. Multivariate analysis identified physical inactivity as the only independent factor associated with worse HRQoL (β = −6.3, P < .001).

Conclusion

Our study shows that AML survivors experience physical limitations and a high comorbidity burden even many years after diagnosis, and it provides insights to better inform survivorship care programs. Further research examining the relationship between physical activity and HRQoL in long-term AML survivors is warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quality of LifeLeukemia, Myeloid, AcuteLife StyleCancer SurvivorsHumansFemaleMiddle AgedMaleAgedCross-Sectional StudiesSurveys and QuestionnairesComorbidity

Stichwörter der Autor:innen

acute myeloid leukemiahealth-related quality of lifehematologic neoplasmslong-term cancer survivorspatient-reported outcomequality of life

Autor:innen und Institutionen

  • Data Center and Health Outcomes Research Unit, Italian Group for Adult Hematologic Diseases (GIMEMA), Rome 00182, Italy.
  • Hospices Civils de Lyon, Department of Clinical Hematology, Centre Hospitalier Lyon-Sud, Pierre Bénite 69495, France.
  • Department of Hematology, Ankara University Faculty of Medicine, Ankara 06620, Turkey.
  • Haematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome 00161,Italy.
  • SC Ematologia 2, AOU Città della Salute e della Scienza, Torino 10126, Italy.
  • Hematology, Fondazione Policlinico Tor Vergata, Rome 00133, Italy.

ORCID-Profile: Fabio Efficace

Förderung

  • EORTC Quality of Life Group

Zitieren

APA

Efficace, F., Cannella, L., Thomas, X., Yuksel, M. K., Trisolini, S. M., Capria, S., Sparano, F., Baldi, T., Audisio, E., Maurillo, L., Lemoli, R. M., Imovilli, A., Panovska-Stavridis, I., Quattrone, M., Ciccone, M., Filardi, N., Fracchiolla, N., Vallisa, D., Crugnola, M., …, & GIMEMA, EORTC Leukemia, and EORTC Quality of Life Group (2026). Long-term health-related quality of life and lifestyle behavior of patients with acute myeloid leukemia. The Oncologist. https://doi.org/10.1093/oncolo/oyag027

Vancouver

Efficace F, Cannella L, Thomas X, Yuksel MK, Trisolini SM, Capria S, et al. Long-term health-related quality of life and lifestyle behavior of patients with acute myeloid leukemia. The Oncologist. 2026. doi:10.1093/oncolo/oyag027

BibTeX
@article{Efficace2026,
  author = {Efficace, Fabio and Cannella, Laura and Thomas, Xavier and Yuksel, Meltem Kurt and Trisolini, Silvia Maria and Capria, Saveria and Sparano, Francesco and Baldi, Thomas and Audisio, Ernesta and Maurillo, Luca and Lemoli, Roberto Massimo and Imovilli, Annalisa and Panovska-Stavridis, Irina and Quattrone, Martina and Ciccone, Maria and Filardi, Nunzio and Fracchiolla, Nicola and Vallisa, Daniele and Crugnola, Monica and Melillo, Lorella Maria Antonia and Skerget, Matevz and Vignetti, Marco and Baron, Frederic and GIMEMA, EORTC Leukemia, and EORTC Quality of Life Group, GIMEMA, EORTC Leukemia, and EORTC Quality of Life Group},
  title = {Long-term health-related quality of life and lifestyle behavior of patients with acute myeloid leukemia},
  journal = {The Oncologist},
  year = {2026},
  doi = {10.1093/oncolo/oyag027}
}
Kostenlos starten →